AIROLDI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 16.731
EU - Europa 10.050
AS - Asia 7.836
SA - Sud America 1.160
AF - Africa 125
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 8
Totale 35.939
Nazione #
US - Stati Uniti d'America 16.268
IT - Italia 2.760
SG - Singapore 2.290
CN - Cina 2.001
DE - Germania 1.927
VN - Vietnam 1.568
RU - Federazione Russa 1.013
BR - Brasile 945
HK - Hong Kong 897
SE - Svezia 862
IE - Irlanda 563
PL - Polonia 536
GB - Regno Unito 478
UA - Ucraina 410
DK - Danimarca 365
CA - Canada 350
FR - Francia 336
IN - India 261
FI - Finlandia 192
AT - Austria 162
ID - Indonesia 127
TR - Turchia 119
KR - Corea 116
NL - Olanda 108
ES - Italia 87
JP - Giappone 86
AR - Argentina 83
MX - Messico 76
BD - Bangladesh 73
ZA - Sudafrica 57
BE - Belgio 46
PK - Pakistan 46
IQ - Iraq 42
RO - Romania 35
CH - Svizzera 33
EC - Ecuador 33
UZ - Uzbekistan 29
PT - Portogallo 27
CZ - Repubblica Ceca 25
LT - Lituania 24
CL - Cile 23
CO - Colombia 23
IR - Iran 23
TW - Taiwan 22
PE - Perù 21
AU - Australia 20
SA - Arabia Saudita 19
EG - Egitto 18
PH - Filippine 17
JO - Giordania 15
MA - Marocco 13
VE - Venezuela 12
GR - Grecia 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 9
MY - Malesia 9
TN - Tunisia 9
BY - Bielorussia 8
EU - Europa 8
IL - Israele 8
KE - Kenya 8
NZ - Nuova Zelanda 8
PY - Paraguay 8
CR - Costa Rica 7
DZ - Algeria 7
HU - Ungheria 7
SV - El Salvador 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
NP - Nepal 6
SY - Repubblica araba siriana 6
GE - Georgia 5
RS - Serbia 5
AL - Albania 4
AM - Armenia 4
BG - Bulgaria 4
BO - Bolivia 4
HN - Honduras 4
LB - Libano 4
LV - Lettonia 4
TH - Thailandia 4
BH - Bahrain 3
CY - Cipro 3
EE - Estonia 3
KH - Cambogia 3
LU - Lussemburgo 3
PA - Panama 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
Totale 35.921
Città #
Ann Arbor 4.738
Singapore 1.422
Ashburn 1.305
Frankfurt am Main 1.201
Milan 1.104
Woodbridge 1.000
Wilmington 923
Hong Kong 886
Fairfield 846
Chandler 763
Houston 586
Dublin 541
Kraków 476
Dallas 438
Ho Chi Minh City 407
Jacksonville 398
Seattle 376
Beijing 373
New York 367
Hanoi 357
Santa Clara 323
Dearborn 289
Cambridge 280
Los Angeles 248
Hefei 212
Princeton 196
Dong Ket 170
Guangzhou 133
Vienna 131
Nanjing 129
Shanghai 118
Buffalo 98
São Paulo 98
Toronto 98
Seoul 95
Jakarta 89
Lawrence 87
Chicago 85
Moscow 79
Altamura 78
The Dalles 75
Rome 72
Helsinki 70
Munich 70
Boardman 68
Hangzhou 67
Montréal 64
Lachine 63
Kent 56
San Diego 53
Council Bluffs 49
Brooklyn 48
London 48
Chennai 46
Nuremberg 45
Tokyo 45
Nanchang 43
Brussels 42
Ottawa 41
Tianjin 41
Desio 40
Da Nang 39
Denver 39
Warsaw 39
Fremont 38
Orem 37
Andover 36
Changsha 36
Grafing 36
Poplar 35
Shenyang 34
Stockholm 34
Turku 34
Ha Long 33
Haiphong 33
Brescia 32
Montreal 32
Manchester 31
Phoenix 31
Biên Hòa 30
Boston 29
Florence 29
Hebei 28
Jinan 28
Cinisello Balsamo 27
Hải Dương 27
Johannesburg 27
Mexico City 27
Quận Bình Thạnh 27
Tashkent 27
Ankara 26
Atlanta 26
Hyderabad 26
Dhaka 25
Ninh Bình 24
Parma 24
Pune 24
Amsterdam 23
Paris 22
Rio de Janeiro 22
Totale 23.866
Nome #
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 729
Coffee variety, origin and extraction procedure: Implications for coffee beneficial effects on human health 693
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 673
Green coffee extract enhances oxidative stress resistance and delays aging in Caenorhabditis elegans 613
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 598
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 593
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 591
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 553
Natural compounds in cancer prevention: effects of coffee extracts and their main polyphenolic component 5-CQA on oncogenic Ras proteins 544
Methacycline displays a strong efficacy in reducing toxicity in a SCA3 Caenorhabditis elegans model 540
Xanthohumol destabilizes the structure of amyloid-β (Aβ) oligomers and promotes the formation of high-molecular-weight amorphous aggregates 534
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 487
Sugar-derived Ras inhibitors: Group epitope mapping by NMR spectroscopy and biological evaluation 485
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 469
Re LPS biogenetic pathway: Enzyme characterisation and synthetic efforts towards inhibitors 468
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 461
Glycoconjugates in cancer therapy 461
Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural cells and Caenorhabditis elegans animal model 449
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 445
Glycan carriers as glycotools for medicinal chemistry applications 445
Studies on the mechanism of action of a new class of inhibitors of Ras activation 441
Nuclear Magnetic Resonance as an Attractive Resource for Monitoring Surveillance Candidates of Acute and Chronic Lung Disorders 412
Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide 409
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 404
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 404
Flavonoids in the treatment of alzheimer’s and other neurodegenerative diseases 389
bioNMR-based identification of natural anti-Aβ compounds in Peucedanum ostruthium 370
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages 362
From cancer metabolism to new biomarkers and drug targets 349
Phosphonate Analogues of Arabinose 5-Phosphate: Putative Ligands for Arabinose 5-Phosphate Isomerases 337
On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor 336
Effectiveness of Vigna unguiculata seed extracts in preventing colorectal cancer 336
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 335
Flavonoids and their glycosides as anti-amyloidogenic compounds: Aβ1-42 interaction studies to gain new insights on their potential for Alzheimer's disease prevention and therapy 333
Methionine supplementation stimulates mitochondrial respiration 328
Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors 327
Versatile and efficient targeting using a single nanoparticulate platform: Application to cancer and alzheimer's disease 326
New targets for antibacterial design: Kdo biosynthesis and LPS machinery transport to the cell surface 322
Enhanced amino acid utilization sustains growth of cells lacking Snf1/AMPK 320
Natural glycoconjugates with antitumor activity 319
How Epigallocatechin-3-gallate and Tetracycline Interact with the Josephin Domain of Ataxin-3 and Alter Its Aggregation Mode 316
Metabolomic profiling of beers: Combining 1H NMR spectroscopy and chemometric approaches to discriminate craft and industrial products 314
1H NMR to Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification 307
Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid b1-42 peptide 306
Structural modifications of cis-glycofused benzopyran compounds and their influence on the binding to amyloid-β peptide 305
Targeting bacterial biofilm: a new LecA multivalent ligand with inhibitory activity 299
Curcumin derivatives as new ligands of Aβ peptides 298
Cis-Glyco-Fused Benzopyran Derivatives as Hit Compounds for the Development of Therapeutic and Diagnostic Tools against Neurodegenerative Diseases 297
NMR analysis of budding yeast metabolomics: A rapid method for sample preparation 297
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 297
The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and developmen 294
Carbohydrate Mimetics and Scaffolds: Sweet Spots in Medicinal Chemistry 293
Towards a universal approach based on omics technologies for the quality control of food 291
Carbohyrate scaffolds in chemical genetic studies 286
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 284
Targeting bacterial membranes: NMR spectroscopy characterization of substrate recognition and binding requirements of D-arabinose-5-phosphate isomerase 282
Antimicrobial peptides: Insights into membrane permeabilization, lipopolysaccharide fragmentation and application in plant disease control 282
Synthesis and biological evaluation of arabinose 5-phosphate mimics modified at position five 278
Cell-Free and In Vivo Characterization of the Inhibitory Activity of Lavado Cocoa Flavanols on the Amyloid Protein Ataxin-3: Toward New Approaches against Spinocerebellar Ataxia Type 3 275
Synthesis and biological evaluation of a small library of nojirimycin derived bicyclic iminosugars 274
The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins 263
NMR Molecular Recognition Studies for the Elucidation of Protein and Nucleic Acid Structure and Function 263
1H NMR to Explore the Metabolome of Exhaled Breath Condensate in α1-Antitrypsin Deficient Patients: A Pilot Study 263
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 262
Targeting Bacterial Membranes: Identification of Pseudomonas aeruginosaD-Arabinose-5P Isomerase and NMR Characterisation of its Substrate Recognition and Binding Properties 260
Curcumin derivatives: Aβ-ligands as potential diagnostic and therapeutic tools for alzheimer's disease 257
Fructose-based proline analogues: Exploring the prolyl trans/cis-amide rotamer population in model peptides 253
Multivalent calix[4]arene-based mannosylated dendrons as new FimH ligands and inhibitors 252
Solid-phase supported mimic of GDP-l-galactose 248
Cheese-whey permeate improves the fitness of Escherichia coli cells during recombinant protein production 246
On-cell NMR screening of multivalent ligands for bacterial targeting 245
Fluorinated Arabinose-5-Phosphate Analogues as Potential Antibactericals 244
Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs 241
Tetracycline prevents Aβ oligomer toxicity through an atipical supramolecular interaction 239
On-cell Saturation Transfer Difference NMR for the identification of FimH ligands and inhibitors 239
NMR Protein-Ligand Interaction Studies under Non-Homogeneous Conditions for Biomaterial Generation: A Model For Artificial Lectin-Carbohydrate Recognition 234
Cis-glyco-fused benzopyran compounds as new amyloid β peptide ligands 233
Fluorescent amyloid β-peptide ligand derivatives as potential diagnostic tools for Alzheimer's disease 231
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 228
Exploiting the Therapeutic Potential of 8-β-d-Glucopyranosylgenistein: Synthesis, Antidiabetic Activity, and Molecular Interaction with Islet Amyloid Polypeptide and Amyloid β-Peptide (1-42) 228
Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1-42, PrP106-126, and Ataxin-3 Oligomers 224
Nutraceutical approach to increase healthy aging using Caenorhabditis elegans as a model organism 219
Development of new potential antitumor drugs based on Ras protein inhibition 216
Sugar-Based Enantiomeric and Conformationally Constrained Pyrrolo[2,1-c][1,4]-Benzodiazepines as Potential GABAALigands 211
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 210
Synthesis of 3-Deoxy-D-threopentofuranose 5-Phosphate, a Substrate of Arabinose 5-Phosphate Isomerase 208
A Contribution to the Harmonization of Non-targeted NMR Methods for Data-Driven Food Authenticity Assessment 205
Clustering Zwitterionic Amino Acids at the Upper Rim of Cone Calix[4]arene Triggers the Selective Recognition of Gram-Negative Bacterial Envelope 203
Aβ Monomers, Oligomers and Fibrils: Structural Features 203
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 200
Antarctic Soil Metabolomics: A Pilot Study 196
New C-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. Therapeutic applications of the synthesized agent(s) and of Genista tenera ethyl acetate extracts containing some of those agents 195
Saturation Transfer Difference NMR Experiments of Membrane Proteins in Living Cells under HR-MAS Conditions: the Interaction of the SGLT1 Co-transporter with Its Ligands 193
Global Scientific Challenges: Perspectives from Young Scientists 192
Natural Compounds against Alzheimer´s Disease: Molecular Recognition of Aβ1–42 Peptide by Salvia sclareoides Extract and its Major Component, Rosmarinic Acid, as Investigated by NMR 192
New tricyclic compounds, process for their manufacture and their use as ligands of beta-alyloid peptides 189
Synthesis of C- and S-Glycosides 188
Performance Assessment in Fingerprinting and Multi Component Quantitative NMR Analyses 186
Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models 185
Mechanistic and Structural Insights on Difluoromethyl-1,3,4-Oxadiazole Inhibitors of HDAC6 182
Totale 32.791
Categoria #
all - tutte 104.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.884 0 0 0 0 0 376 362 404 375 494 294 579
2021/20223.283 308 342 310 309 161 271 222 154 283 246 273 404
2022/20233.885 498 944 488 370 326 514 127 195 199 57 99 68
2023/20242.424 104 119 158 188 269 483 376 131 181 68 99 248
2024/20255.977 282 582 519 308 425 274 279 230 594 881 543 1.060
2025/20268.004 2.067 1.116 1.270 1.720 1.707 124 0 0 0 0 0 0
Totale 37.017